wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48194503-21E2A978-C2F2-4215-AD7E-D53A2F40ECAE
Q48194503-21E2A978-C2F2-4215-AD7E-D53A2F40ECAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194503-21E2A978-C2F2-4215-AD7E-D53A2F40ECAE
Immunotherapy as an Option for Cancer Treatment.
P2860
Q48194503-21E2A978-C2F2-4215-AD7E-D53A2F40ECAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194503-21E2A978-C2F2-4215-AD7E-D53A2F40ECAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4b898a06c918b3fc4984e41820fe6bb34cd26f0
P2860
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.